On Wednesday, Shares of Douglas Emmett, Inc. (NYSE:DEI), lost -1.47% to $30.08.
Douglas Emmett, declared that it has closed a secured, non-recourse $400 million interest only loan that will mature in November 2022. The loan bears interest at a floating rate of Libor plus 1.35% which has been fixed at 2.64% per annum until November 2020 through an interest rate swap. The new loan is secured by a pool of seven of Douglas Emmett’s office properties.
Douglas Emmett is using about $254 million of the proceeds to pay down the outstanding balance of its existing $510 million loan due April 2, 2018.
Douglas Emmett, Inc., a real estate investment trust, owns and operates office and multifamily properties in California and Hawaii. As of December 31, 2007, the company’s office portfolio compriseed of 48 properties and multifamily portfolio compriseed of 9 properties.
Shares of Kansas City Southern (NYSE:KSU), inclined 0.23% to $96.39, during its last trading session.
Kansas City Southern, has published its annual Sustainability Report covering the company’s activities in 2014. The report is now available on the newly improved www.kcsouthern.com in the Corporate Responsibility and Investors sections. It highlights the company’s position and progress on social, environmental and economic topics.
Some of the sustainability highlights in 2014 comprise implementation of new technologies to further improve safety and security counting technology that detects potential safety rules violations involving the inappropriate use of cell phones in locomotive cabs; a new mobile security application that enhances safety and security by allowing real time reporting of events to allow faster response when needed; and new sustainable technology improvements. The report also highlights KCS’ participation in the See Tracks? Think Train! grade crossing safety campaign and its receipt of awards from customers and TRANSCAER®.
The report also reinforces KCS’ commitment to service quality and customer satisfaction; the safety of employees and the communities through which the railroad operates; responsible environmental stewardship; positive corporate citizenship through community engagement, charitable giving and volunteerism; providing employees with tools for a fulfilling career and healthy life; and delivering value to shareholders.
Kansas City Southern, through its auxiliaries, engages in the freight rail transportation business. It operates north/south rail route between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States.
Finally, St. Jude Medical, Inc. (NYSE:STJ), ended its last trade with -0.92% loss, and closed at $65.88.
St. Jude Medical, declared results from the SHIELD I (Coronary InterventionS in HIgh-Risk PatiEnts Using a Novel Percutaneous Left Ventricular Support Device) study that confirm the benefits of the HeartMate PHP™ (Percutaneous Heart Pump) cardiac assist device for patients undergoing high-risk percutaneous coronary intervention (PCI), a procedure to restore blood flow to the heart. The study demonstrated that compriseent, stable hemodynamics were maintained during revascularization when assisted by the HeartMate PHP cardiac assist device.
SHIELD I is a prospective, nonrandomized, open-label, multicenter trial that evaluated the use of the HeartMate PHP cardiac assist device in patients who required hemodynamic (circulatory) support during complex PCI procedures. The study results from the first 46 patients were presented at the 27th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco, Calif.
“We are excited to share the results of SHIELD I, which support the safety and performance of the HeartMate PHP device,” said Dr. Dariusz Dudek, principal investigator of the SHIELD I study and Physician in Chief, Department of Cardiology and Cardiovascular Interventions at the University Hospital in Krakow, Poland. “The data from SHIELD I demonstrate that the HeartMate PHP device is a highly promising technology that should be considered for high-risk patients, such as those with advanced heart failure or who may be at risk of cardiogenic shock, undergoing PCI procedures.”
St. Jude Medical, Inc., together with its auxiliaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm administration, cardiovascular, and atrial fibrillation therapy areas worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
